Clinical Trial Update: A Phase I Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine and 14-valent Pneumococcal Conjugate Vaccine in Adults [Phase 1]

View source ↗

Summary

Phase I clinical trial update on LG Life Sciences' 13-valent and 14-valent pneumococcal conjugate vaccines in adults has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Infections

Drugs mentioned

• 13-valent pneumococcal conjugate vaccine (13-valent pneumococcal conjugate vaccine)
• 14-valent Pneumococcal Conjugate Vaccine (Pneumococcal conjugate vaccine, 14-valent)

Snippet

Sponsor: LG Life Sciences | Conditions: Pneumococcal Infections | Phase 1 | Status: COMPLETED